Page 2,791«..1020..2,7902,7912,7922,793..2,8002,810..»

How to Get Rid Of Eczema and Nose Ring Bump/Keloids – Video

Posted: Published on January 17th, 2015

How to Get Rid Of Eczema and Nose Ring Bump/Keloids Hey yall!! It's Ragin here with Mixed Up With it just sharing with you some of my tips for controlling eczema and nose ring bumps/keloids!! I hope this helps because it has helped me tons!!... By: Mixed Up With It … Continue reading

Posted in Eczema | Comments Off on How to Get Rid Of Eczema and Nose Ring Bump/Keloids – Video

Eczema Impact Runs Deeper Than Skin, Says Study

Posted: Published on January 17th, 2015

The term "eczema" has its origin in the Greek word "ekzein", which means to effervesce or bubble or boil over. It is estimated that over 30 million Americans suffer from this chronic skin disease. Dry, sensitive skin, intense itching, red patches and recurring rash are some of the symptoms associated with eczema. But if you thought that eczema sufferers' woes are only skin deep, you are wrong, and here's why... A study conducted by Northwestern Medicine has found that adults who have eczema have higher rates of smoking, drinking alcoholic beverages and obesity than people who don't have the disease. In addition, eczema sufferers are less likely to exercise because their condition may worsen as a result of triggers such as sweat and heat. The plethora of bad health habits gives the eczema sufferers a higher risk of cardiovascular disease, including high blood pressure and high cholesterol as well as diabetes. They also have higher rates of insomnia, reveals the study. As part of the study, the researchers analysed data for 27,157 and 34,525 adults aged 18 to 85 years from the 2010 and 2012 National Health Interview Survey, respectively. According to the study results, patients with eczema had 54% … Continue reading

Posted in Eczema | Comments Off on Eczema Impact Runs Deeper Than Skin, Says Study

"Breakthrough therapy" could help treat eczema

Posted: Published on January 17th, 2015

About 30 million Americans suffer from eczema, a painful, itchy skin condition that can be hard to treat and miserable to live with. Now the Food and Drug Administration has fast-tracked testing of a promising new drug treatment that could offer patients new hope. Daniela Velasco is one of the patients taking part in testing the drug, called Dupilumab, at Mount Sinai Hospital in New York City, and she's amazed by the difference it has made. Velasco suffered from flare-ups so severe they kept her awake at night. Now she says her skin looks healthy for the first time in four years. "It was such a quick change, so dramatic," she told CBS News. "Like from being extremely miserable to like, 'Whoa, this is what it feels like to be normal again!'" The itchy, red patches on her legs cleared up within 10 days. Doctors say 85 percent of the patients taking the drug in the study experienced similar results. Dupilumab, which is administered by injection, was developed by Regeneron Pharmaceuticals, Inc. and Sanofi. It was recently designated a "Breakthrough Therapy" by the FDA to accelerate the testing process and speed its way towards approval. The drug was developed based … Continue reading

Posted in Eczema | Comments Off on "Breakthrough therapy" could help treat eczema

FDA Fast-Tracks Eczema Drug

Posted: Published on January 17th, 2015

Daniela Velasco's skin looks healthy for the first time in 4 years. "You see that it's quite normal now. It's unbelievable." Velasco suffers with severe eczema. The painful, itchy flareups would keep her up all night. "The itch doesn't go away." In August, Velasco joined a study at Mount Sinai Hospital in New York that's testing a new drug called Dupilumab. She says the skin on her legs went from this...to this in just 10 days. "Literally, they were disappearing, the wounds were closing. And it was such a quick change, so dramatic. Like from being extremely miserable to like, woah, this is what it feels like to be normal again." 85 percent of the patients in the study taking the drug experienced similar results. Dr. Emma GuttmanYassky lead the research which found eczema is an immune driven disease. The rest is here: FDA Fast-Tracks Eczema Drug … Continue reading

Posted in Eczema | Comments Off on FDA Fast-Tracks Eczema Drug

Coventry mum's bid to get pioneering drug for five-year-old son

Posted: Published on January 17th, 2015

A Coventry mum travelled to Downing Street in her bid to get the pioneering drug that could help save her sons life. Jaspal Mann has watched on as her five-year-old son Kirath has battled against muscle-wasting condition Duchenne muscular dystrophy, which leaves many children in a wheelchair before their 10th birthday. Problems with heart and lung muscles also mean that few with the condition currently live to see their 30th birthday. The desperate mum, from Westwood Heath, joined other families from across the country and members of the Muscular Dystrophy Campaign as they handed over a petition to MPs and peers in Westminster calling on the NHS to end delays to a breakthrough treatment called Translarna. The drug is the first ever to tackle the causes of Duchenne muscular dystrophy. It was approved in Europe in August and is currently available in France, Spain, Germany, Italy and Denmark. However, NHS administrative issues have led to agonising delays for families in the UK. Jaspal, 38, said: Kirath loves nothing more than talking to his friends about his favourite super heroes, dinosaurs and playing with his toy cars. Simply put, Kirath just wants to be one of the boys. Although hes still … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Coventry mum's bid to get pioneering drug for five-year-old son

Why Suramin, a Century-Old, Anti-Parasitic Drug May Hold the Key to Understanding Autism

Posted: Published on January 17th, 2015

Contact Information Available for logged-in reporters only Newswise Robert Naviaux MD Ph.D, who is a professor of genetics and Co-Director of the Mitochondrial and Metabolic Disease Center at the University of California, San Diego School of Medicine researcher has published another potential breakthrough piece of autism research that finds that the 100 year old anti-parasitic drug, suramin, corrects the autism-like behaviors in the fragile X mouse model. Fragile X is a genetic condition that often leads to autism. This is the second autism mouse model that Dr. Naviaux has shown suramin to be effective in. The paper is published in the journal Molecular Autism This finding builds upon his previous work with suramin in the Maternal Immune Activation (MIA) mouse model, where suramin was also shown to be effective. Unlike the Fragile X model, which is a genetic mouse model, the MIA mouse model relies on a simulated infection during pregnancy to induce autism-like features in male offspring. Together these findings build a strong case that Dr. Naviaux has identified an elusive core, common mechanism in autism theorized to exist and one that is potentially amenable to treatment in humans with an existing drug. John Rodakis, Founder of N of … Continue reading

Comments Off on Why Suramin, a Century-Old, Anti-Parasitic Drug May Hold the Key to Understanding Autism

Study: Century-Old Drug May Be Key to Autism Cure

Posted: Published on January 17th, 2015

Boy with autism. Photo credit: Scott Vaughan/Wiki Commons Researchers at the UC San Diego School of Medicine saidThursday that a century-old drug corrects genetic autism symptoms in laboratory mice, which might suggest a pathway for treatment in humans. The drug is suramin, which has been used for decades to treat trypanosomiasis, a parasitic disease found in sub-Saharan Africa thats also known as Sleeping Disease. The illness comes in two stages, the first of which doesnt show symptons, but the second which strikes years later impacts the central nervous system and upsets the sleep cycle. UCSD scientists previously found that suramin corrected environmentally caused autism symptoms in mice, but this is the first time the same result has been seen in genetic autism. Autism spectrum disorders affect 1 to 2 percent of children in the United States, and hundreds of genetic and environmental factors have been shown to increase the risk, according to UCSD. Correcting abnormalities in a mouse is a long way from a cure in humans, but our study adds momentum to discoveries at the crossroads of genetics, metabolism, innate immunity, and the environment for several childhood chronic disorders, said Dr. Robert Naviaux, a UCSD professor of medicine. These … Continue reading

Comments Off on Study: Century-Old Drug May Be Key to Autism Cure

New Program Tries To Reduce Wait For Stroke Treatment – Video

Posted: Published on January 17th, 2015

New Program Tries To Reduce Wait For Stroke Treatment Stroke is the third leading cause of death in the U.S. claiming the lives of more than 140000 Americans each year. But many lives could be spared if treatment was given sooner. Now, a new... By: NewsChannel 5 … Continue reading

Comments Off on New Program Tries To Reduce Wait For Stroke Treatment – Video

More effective treatments on the horizon for Parkinson's patients

Posted: Published on January 17th, 2015

Parkinson's disease affects about six million people worldwide and does not have a cure. Still, researchers are learning more and more about the disease every day. Now, an old drug may offer patients new hope. Dr. David Higgins lives a busy and active life but, a few years ago, some mysterious symptoms threatened to slow him down. "I was having trouble swimming and I was having trouble running, says Higgins. Stiffness, soreness, lack of control." David was diagnosed with Parkinsons, a disease that affects movement. "It does not make me feel good about the future, says Higgins. However, neurologist Irene Litvan says the future is looking brighter for people like Higgins. Litvan is studying a new therapy for Parkinsons that is already being used to treat high blood pressure. The good thing is that multiple people have taken it, says Litvan. See more here: More effective treatments on the horizon for Parkinson's patients … Continue reading

Posted in Parkinson's Treatment | Comments Off on More effective treatments on the horizon for Parkinson's patients

Fears cerebral palsy sufferers wont be able to sue under new scheme

Posted: Published on January 17th, 2015

Lawyers fear cerebral palsy sufferers will be stripped of their legal right to sue for medical negligence under a new injury insurance scheme being developed by the federal government. The Australian Lawyers Alliance fear the National Injury Insurance Scheme, if introduced, may mean children who are born with cerebral palsy due to medical malpractice may be unable to take civil action to compensate for lifetime care and support. The alliance has pointed to a major negligence case in the ACT, in which a family settled for $7.5 million, as evidence of the importance of civil action in such cases. In that case, the family had alleged that malpractice at Canberra Hospital caused their son's cerebral palsy when he was born, and settled recently after action in the ACT Supreme Court. Advertisement The alliance has warned that plans to introduce a National Injury Insurance Scheme, which is being developed alongside the National Disability Insurance Scheme, could prevent sufferers from taking similar action. But the federal government said no decision had been made on such an approach, and that full consultation on the scheme was yet to take place. "A decision regarding the implementation of a NIIS for medical treatment accidents will … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Fears cerebral palsy sufferers wont be able to sue under new scheme

Page 2,791«..1020..2,7902,7912,7922,793..2,8002,810..»